Background MLC601 is a possible modulator of amyloid precursor proteins handling, and in a clinical trial research MLC601 showed some efficiency in cognitive function in Alzheimer’s disease (Advertisement) sufferers. Altogether, 39 sufferers (14.7%) still left the study. Development of cognition adjustments predicated on the adjustments over enough time for MMSE and ADAS-cog ratings didn’t differ… Continue reading Background MLC601 is a possible modulator of amyloid precursor proteins handling,